688108.SS SHH
Sino Medical Sciences Technology Inc.
1W: -7.5%
1M: -11.0%
3M: -22.6%
YTD: -33.8%
1Y: -27.2%
3Y: +47.2%
5Y: +21.9%
¥14.87 ($2.22)
+0.22 (+1.50%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$525M
+14.5% ▲
5Y CAGR: +9.9%
Gross Profit
$525M
+97.4% ▲
5Y CAGR: +15.1%
Operating Income
$67M
+493.8% ▲
5Y CAGR: +22.7%
Net Income
$47M
+3057.1% ▲
5Y CAGR: +16.0%
EPS (Diluted)
$0.11
+2650.0% ▲
5Y CAGR: +14.9%
EBITDA
$133M
+149.8% ▲
5Y CAGR: +21.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $194M | $193M | $343M | $459M | $525M |
| YoY Growth | -40.6% | -0.8% | +78.0% | +33.6% | +14.5% |
| Cost of Revenue | $60M | $86M | $146M | $193M | $238M |
| Gross Profit | $134M | $107M | $198M | $266M | $525M |
| Gross Margin | 69.0% | 55.6% | 57.6% | 58.0% | 100.0% |
| R&D Expenses | $149M | $153M | $114M | $141M | $0 |
| SG&A Expenses | $149M | $174M | $157M | $168M | $0 |
| Operating Expenses | $297M | $326M | $267M | $283M | $459M |
| Operating Income | -$163M | -$219M | -$69M | -$17M | $67M |
| Operating Margin | -84.0% | -113.6% | -20.2% | -3.7% | 12.7% |
| Interest Expense | $2M | $3M | $4M | $6M | $5M |
| Income Before Tax | -$163M | -$221M | -$68M | -$17M | $68M |
| Tax Expense | -$32M | -$48M | -$24M | -$13M | $21M |
| Net Income | -$131M | -$162M | -$40M | $1M | $47M |
| Net Margin | -67.3% | -84.2% | -11.5% | 0.3% | 9.0% |
| EPS (Diluted) | $-0.32 | $-0.40 | $-0.10 | $0.00 | $0.11 |
| EBITDA | -$114M | -$172M | -$24M | $30M | $133M |
| Shares Outstanding | 410M | 410M | 396M | 374M | 430M |